Powered by Smartsupp

Laser blood irradiation: ILIB, VPBM and research findings

KINGRAY Academy · guide to light research
KINGRAY Academy · Heart, blood and blood vessels

KINGRAY Academy · Heart, blood and blood vessels · Article 13

Author: Ing. František Kokoš · Updated:
First published:

What is laser blood irradiation?

In laser blood irradiation and related forms of photobiomodulation, researchers investigate how light affects blood markers and cellular processes. The procedures differ in whether light is delivered directly into a vein, through the skin or through the nasal lining.

Which questions will this article answer?

  • What do ILIB and VPBM stand for, and how do they differ?
  • Is intranasal application as effective as intravenous blood irradiation?
  • What has research shown about blood viscosity and blood cell aggregation?
  • Which colours and wavelengths of light do researchers use, and why?
  • What have studies found in diabetes and diabetic complications?
  • How might ILIB or VPBM affect inflammation and the immune system?
  • Is photobiomodulation part of medical research?
  • How many scientific studies exist, and where can we find them?
  • What do we know about safety and long-term use?
  • What has research shown about memory, attention and brain function?

In this part, we explore these questions through specific scientific studies, their encouraging findings and the issues that further research needs to clarify. For each study, we explain how the light was delivered and what the researchers actually measured.

We explain the differences between ILIB, VPBM and intranasal photobiomodulation, the importance of light colour and dose, and research findings on blood flow, inflammation, diabetes and brain function. More complex concepts are also explained in simple terms.

Heart series · all 15 articles
Article contents

What do ILIB and VPBM stand for, and how do they differ?

Illustration of blood cells; it does not depict a laser procedure or a treatment outcome.
Illustration of blood cells; it does not depict a laser procedure or a treatment outcome.

In ILIB, light is delivered through an optical fibre directly into a vein. VPBM stands for vascular photobiomodulation; recent publications often use it for light applied through the skin over a vascular area, such as the wrist. Intranasal application uses the nasal lining and is also called intranasal photobiomodulation.

Terminology is not consistent across all publications. We therefore specify where the researchers applied the light in each study.

Sources: [1], [3]

Is intranasal application as effective as intravenous blood irradiation?

Intranasal application has encouraging clinical findings of its own. In a 2012 study, Liu and colleagues investigated a 650 nm red laser in 90 patients. They reported favourable changes in several blood markers in the active group.

This route does not require an optical fibre to be inserted into a vein. However, the study compared intranasal application with an inactive device, not directly with ILIB. Direct comparative studies are needed to establish equivalent effectiveness.

Sources: [2]

What has research shown about blood viscosity and blood cell aggregation?

In that intranasal study, the authors reported reductions in plasma viscosity, red blood cell aggregation and whole-blood viscosity under one of the measured flow conditions. Not every measured value changed significantly.

The groups differed at baseline, and the analysis relied mainly on comparisons before and after application. The findings therefore provide a reason for more rigorous confirmation. The study did not demonstrate clot dissolution or prevention of heart attacks or strokes.

Sources: [2]

Which colours and wavelengths of light do researchers use, and why?

Red and near-infrared light are frequently studied. The intranasal study used 650 nm; other studies investigate wavelengths such as 660 or 808 nm. Research also includes other colours. Wavelengths differ in their penetration into tissue and in which molecules absorb the light.

Researchers investigate several mechanisms, including cellular signalling and mitochondrial processes. No single colour is universally best for every procedure. Power, illuminated area, time and application site also influence the outcome.

Sources: [4], [7]

What have studies found in diabetes and diabetic complications?

A small study of intravenous application in nine people with type 2 diabetes reported lower blood glucose and changes in several metabolites.

In a 2026 study of 15 patients taking metformin, transcutaneous VPBM was associated with lower blood glucose immediately after sessions and lower fasting glucose at the end of follow-up. HbA1c did not change significantly. The study had no control group, so it cannot separate the effect of light from other influences.

The findings support further metabolic research. They do not, on their own, establish prevention of diabetic complications or the effectiveness of intranasal application for diabetes. Light does not replace diabetes treatment.

Sources: [5], [6]

How might ILIB or VPBM affect inflammation and the immune system?

One promising direction is modulation of the inflammatory response. A 2024 systematic review included six studies in humans and animals. The authors described favourable changes in some inflammatory and anti-inflammatory signalling substances and in nitric oxide.

These are findings from specific procedures. They cannot be summarised as a universal immune boost or applied to every intranasal device without verification.

Sources: [7]

Is photobiomodulation part of medical research?

Yes. Photobiomodulation is studied at universities and clinical centres. Professional recommendations already exist for certain precisely defined applications, such as preventing oral mucosal damage during selected cancer treatment regimens.

Blood irradiation and intranasal application have their own research base. Their place in routine treatment must be assessed according to the condition, delivery method and quality of clinical outcomes.

Sources: [8], [3]

How many scientific studies exist, and where can we find them?

The number depends on whether the search covers all photobiomodulation, intravenous application, transcutaneous application or intranasal light.

A 2025 review of systemic photobiomodulation included 37 studies: 28 clinical and 9 preclinical. Another review assessed 8 randomised trials involving 340 participants, covering both intravenous and transcutaneous procedures. These counts may overlap and are not a total of all publications.

The expanded source list at the end of this article links to individual publications. A publication title or DOI helps locate the original paper in PubMed or on the publisher’s website.

Sources: [3], [9]

What do we know about safety and long-term use?

The authors of the review of eight randomised trials reported no serious adverse events. This is encouraging, but short-term follow-up does not establish the safety of daily use over many years.

Both the method and the settings matter. For example, two participants in the transcutaneous VPBM study mentioned above experienced local redness and a burning sensation. A biphasic response means that the relationship between dose and effect may not be linear; it does not guarantee that an arbitrarily high dose is harmless.

Sources: [9], [6], [4]

What has research shown about memory, attention and brain function?

A small series of five people with dementia reported improved cognitive test scores after combined transcranial and intranasal light application. The study had no control group.

A 2026 randomised pilot trial involving 20 participants with mild cognitive impairment found favourable differences in global cognition and memory with the investigated protocol compared with the control group. However, findings are not uniform: another randomised dementia trial did not confirm a significant cognitive improvement.

These studies investigate application to the head or combined procedures. With combined head and nasal application, the contributions of the individual components still need to be separated. A better test score does not, by itself, demonstrate regeneration of damaged neurons.

Sources: [10], [11], [12]

Scientific sources

For each publication, we identify the method of light delivery and the type of outcomes investigated.

  1. Fernandes et al. (2021). Vascular Photobiomodulation.

    Expert discussion of terminology and vascular delivery methods; not a clinical trial.

  2. Liu et al. (2012). Randomized, Double-Blind, and Placebo-Controlled Clinic Report of Intranasal Low-Intensity Laser Therapy on Vascular Diseases.

    Intranasal application alone at 650 nm; 90 patients; blood lipids and rheological markers.

  3. Brassolatti et al. (2025). Systemic photobiomodulation: an integrative review of evidence for intravascular laser irradiation of blood and vascular photobiomodulation.

    Review of 37 clinical and preclinical studies with different methods and parameters.

  4. Huang et al. (2011). Biphasic dose response in low level light therapy — an update.

    Review of dose responses and mechanisms investigated in photobiomodulation.

  5. Kazemi Khoo et al. (2013). A metabolomic study on the effect of intravascular laser blood irradiation on type 2 diabetic patients.

    Intravenous application; nine patients; metabolites compared before and after application.

  6. Almeida et al. (2026). Effects of Vascular Photobiomodulation on Glycemic Control in Patients With Type II Diabetes Mellitus: A Prospective Single-Arm Clinical Study.

    Transcutaneous VPBM; 15 patients; six weeks; no control group.

  7. Vasconcelos et al. (2024). Influence of Intravascular Laser Irradiation of Blood (ILIB) on inflammatory cytokines and nitric oxide in vivo: a systematic review.

    Six studies in humans and animals; inflammatory signalling substances and nitric oxide.

  8. MASCC/ISOO. Photobiomodulation for the management of oral mucositis in cancer patients — clinical practice guidelines.

    Recommendations for specified intraoral protocols; not a recommendation for ILIB or intranasal application.

  9. Díaz et al. (2025). The clinical efficacy of intravascular laser irradiation of blood (ILIB): A narrative review of randomized controlled trial.

    Review of eight randomised trials with 340 participants; intravenous and transcutaneous procedures.

  10. Saltmarche et al. (2017). Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report.

    Combined head and nasal application; five cases; no control group.

  11. A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial (2026).

    Randomised pilot trial; 20 participants; cognitive, metabolic and neuroimaging outcomes.

  12. Jarrahi et al. (2025). The Efficacy of Photobiomodulation Therapy in Improving Cognitive Function and Reducing Depression and Anxiety in Patients with Mild-to-Moderate Dementia: A Double-Blinded Randomized Clinical Trial.

    Randomised trial with 30 participants; no significant between-group difference in cognition was confirmed.

⚠️ Important health information
This is an educational article and does not replace medical examination, diagnosis or treatment. It is neither a guide to laser irradiation of blood at home nor a recommendation for a specific device. Do not change prescribed treatment, anticoagulant therapy or antiplatelet therapy based on this article. Invasive intravascular procedures belong in a healthcare setting.
Ing. František Kokoš
Author: Ing. František Kokoš
Ing. František Kokoš – Author of KINGRAY Academy and Advice Corner
Technician, nutrition adviser (graduate of the 150-hour Welko retraining programme, 2025) and creator of the KINGRAY nutraceuticals concept. Years of developing the BIOquant medical device and working with blood rheology and tissue oxygenation led him to realise that bodily health requires the full picture – linking microcirculation, cellular energy and proper nutrition. In his articles, he looks for the balance where the body understands and cooperates with us.
He is the author of the book Liečba svetlom (Light Therapy, ISBN 978-80-970512-0-4), co-author of the publication BIOquant – polovodičová laserová terapia (BIOquant – Semiconductor Laser Therapy, ISBN 978-80-970512-2-8), and originator of patents in light technologies (US9731145B2, SK5457Y1).
%s ...
%s
%image %title %code %s
%s